Target intelligence / Profile preview

Germ cell-less 1, spermatogenesis associated (GMCL1)

Target
GMCL1
Molecular classification
Nuclear envelope protein, BTB (POZ) domain-containing protein, Other (not classified as receptor, enzyme, ion channel, transporter, or transcription factor in humans)
01

Overview

GMCL1 (Germ cell-less 1, spermatogenesis associated) encodes a nuclear envelope protein conserved across species and is likely involved in spermatogenesis in humans, either directly or by influencing genes linked to sperm cell development. The protein contains a BTB/POZ domain, a motif commonly found in proteins involved in protein-protein interactions and the regulation of cellular processes. Functional studies in non-human models (e.g., Drosophila) suggest GMCL1 homologs play critical roles in transcriptional suppression, centrosome dynamics, and cell fate determination during early germ cell formation. In mammals, there is preliminary evidence that GMCL1 may influence the p53 pathway by modulating MDM2 degradation, but its direct biological functions in humans remain incompletely defined. GMCL1 is not considered a classical therapeutic target (such as receptor, enzyme, transporter, etc.) and has no established clinical modulators or diagnostic biomarkers.

Other names
GCL1Germ cell-less protein-like 1BTBD13SPATA29Spermatogenesis-associated protein 29FLJ13057Germ cell-less homolog 1
02

Mechanism of action

Not applicable; no drugs known to target GMCL1

03

Biological functions

Spermatogenesis (formation and development of sperm cells)Regulation of nucleocytoplasmic transport (likely by modulating protein movement between nucleus and cytoplasm)Enhancement of MDM2 degradation and p53 stabilization (potentially influencing cell cycle regulation and apoptosis via p53 pathway)In model organisms (Drosophila), transcriptional suppression in germline precursor formation, regulation of centrosome dynamics, and germ cell fate specification
04

Disease associations

No strongly established role in major diseases; associations only tentatively listed for rare syndrome and allergy (Carbapenem allergy, Kinsship syndrome), but not as a classical targetNo clear evidence of direct involvement in cancer, inflammation, neurodegenerative disease, infection, or cardiovascular disease in humans

Beyond the preview

Go deeper on Germ cell-less 1, spermatogenesis associated (GMCL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Germ cell-less 1, spermatogenesis associated (GMCL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call